講演情報
[WS20-15-O/P]Development of novel therapy targeting gut microbiota for primary sclerosing cholangitis.
○Haruka Okada1, Masataka Ichikawa2, Nobuhiro Nakamoto1, Takanori Kanai1 (1.Division of Gastroenterology & Hepatology, Department of Internal Medicine, Keio University School of Medicine, 2.Division of Gastroenterology, TOkyo Dental College Ichikawa General Hospital)
キーワード：
Primary sclerosing cholangitis、bacteriophage、gut microbiota、Klebsiella pneumoniae
閲覧にはパスワードが必要です
ログイン
または